(Q38039856)

27 August 2017

title

Nerve growth factor and Alzheimer's disease: new facts for an old hypothesis (English)

1 reference

27 August 2017

0 references

Antonino Cattaneo

1

1 reference

27 August 2017

Pietro Calissano

series ordinal

2

1 reference

27 August 2017

publication date

1 September 2012

1 reference

27 August 2017

published in

Molecular Neurobiology

1 reference

27 August 2017

volume

46

1 reference

27 August 2017

issue

3

1 reference

27 August 2017

page(s)

588-604

1 reference

https://scigraph.springernature.com/pub.10.1007/s12035-012-8310-9

27 August 2017

exact match

0 references

cites work

The cholinergic hypothesis of geriatric memory dysfunction

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8310-9

Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8310-9

Candidate gene for the chromosome 1 familial Alzheimer's disease locus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8310-9

Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8310-9

Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8310-9

Association of missense and 5'-splice-site mutations in tau with the inherited dementia FTDP-17

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8310-9

The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8310-9

Twenty years of the Alzheimer's disease amyloid hypothesis: a genetic perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8310-9

Amyloid-beta immunisation for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8310-9

Long-term effects of Abeta42 immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8310-9

Will anti-amyloid therapies work for Alzheimer's disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8310-9

Resolving controversies on the path to Alzheimer's therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8310-9

The toxic Aβ oligomer and Alzheimer's disease: an emperor in need of clothes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8310-9

Alzheimer's disease is a synaptic failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8310-9

Anti-aβ therapeutics in Alzheimer's disease: the need for a paradigm shift

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8310-9

Linking Abeta and tau in late-onset Alzheimer's disease: a dual pathway hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8310-9

The nerve growth factor 35 years later

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8310-9

Reduction of cortical TrkA but not p75(NTR) protein in early-stage Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8310-9

Loss of nucleus basalis neurons containing trkA immunoreactivity in individuals with mild cognitive impairment and early Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8310-9

Nerve growth factor mRNA and protein levels measured in the same tissue from normal and Alzheimer's disease parietal cortex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8310-9

Neurotrophic factors in Alzheimer’s disease: role of axonal transport

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8310-9

Early days of the nerve growth factor proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8310-9

Activity-dependent release of precursor nerve growth factor, conversion to mature nerve growth factor, and its degradation by a protease cascade

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8310-9

Regulation of cell survival by secreted proneurotrophins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8310-9

ProNGF: a neurotrophic or an apoptotic molecule?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8310-9

Intrinsic structural disorder of mouse proNGF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8310-9

Sortilin is essential for proNGF-induced neuronal cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8310-9

The precursor pro-nerve growth factor is the predominant form of nerve growth factor in brain and is increased in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8310-9

Amyloid beta-induced nerve growth factor dysmetabolism in Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8310-9

21 January 2018

p75NTR--live or let die.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8310-9

Dissecting the diverse actions of pro- and mature neurotrophins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8310-9

Alzheimer-like neurodegeneration in aged antinerve growth factor transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8310-9

Intranasal administration of nerve growth factor (NGF) rescues recognition memory deficits in AD11 anti-NGF transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8310-9

Failure of nicotine-dependent enhancement of synaptic efficacy at Schaffer-collateral CA1 synapses of AD11 anti-nerve growth factor transgenic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8310-9

Beta-amyloid plaques in a model for sporadic Alzheimer's disease based on transgenic anti-nerve growth factor antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8310-9

Nerve growth factor and galantamine ameliorate early signs of neurodegeneration in anti-nerve growth factor mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8310-9

On the molecular basis linking Nerve Growth Factor (NGF) to Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8310-9

Dissecting NGF interactions with TrkA and p75 receptors by structural and functional studies of an anti-NGF neutralizing antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8310-9

Dissecting the involvement of tropomyosin-related kinase A and p75 neurotrophin receptor signaling in NGF deficit-induced neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8310-9

In the adult hippocampus, chronic nerve growth factor deprivation shifts GABAergic signaling from the hyperpolarizing to the depolarizing direction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8310-9

Early inflammation and immune response mRNAs in the brain of AD11 anti-NGF mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8310-9

Inflammatory changes parallel the early stages of Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8310-9

The classical complement cascade mediates CNS synapse elimination

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8310-9

A dual mechanism linking NGF/proNGF imbalance and early inflammation to Alzheimer's disease neurodegeneration in the AD11 anti-NGF mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8310-9

The blood-brain barrier in health and chronic neurodegenerative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8310-9

Induction of apoptosis in cerebellar granule neurons by low potassium: inhibition of death by insulin-like growth factor I and cAMP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8310-9

A genomic approach to investigate neuronal apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8310-9

Increased amyloidogenic secretion in cerebellar granule cells undergoing apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8310-9

Role of N-terminal tau domain integrity on the survival of cerebellar granule neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8310-9

NMDA receptor mediates tau-induced neurotoxicity by calpain and ERK/MAPK activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8310-9

A peptide containing residues 26-44 of tau protein impairs mitochondrial oxidative phosphorylation acting at the level of the adenine nucleotide translocator.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8310-9

Early release and subsequent caspase-mediated degradation of cytochrome c in apoptotic cerebellar granule cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8310-9

Cytochrome c, released from cerebellar granule cells undergoing apoptosis or excytotoxic death, can generate protonmotive force and drive ATP synthesis in isolated mitochondria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8310-9

Role of the autophagic-lysosomal system on low potassium-induced apoptosis in cultured cerebellar granule cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8310-9

Transfer of the apoptotic message in sister cultures of cerebellar neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8310-9

Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8310-9

Selective vulnerability of corticocortical and hippocampal circuits in aging and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8310-9

NGF and BDNF signaling control amyloidogenic route and Abeta production in hippocampal neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8310-9

Endogenous Aβ causes cell death via early tau hyperphosphorylation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8310-9

Tau and HMW tau phosphorylation and compartmentalization in apoptotic neuronal PC12 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8310-9

Antibodies against beta-amyloid reduce Abeta oligomers, glycogen synthase kinase-3beta activation and tau phosphorylation in vivo and in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8310-9

Abeta immunotherapy leads to clearance of early, but not late, hyperphosphorylated tau aggregates via the proteasome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8310-9

Interaction of tau protein with the dynactin complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8310-9

Role of tau phosphorylation by glycogen synthase kinase-3beta in the regulation of organelle transport

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8310-9

Cytoskeletal transport in the aging brain: focus on the cholinergic system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8310-9

Altered cellular distribution of phospho-tau proteins coincides with impaired retrograde axonal transport in neurons of aged rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8310-9

Neurotrophins and their receptors: a convergence point for many signalling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8310-9

Trk receptors: roles in neuronal signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8310-9

Tyrosine kinase nerve growth factor receptor switches from prosurvival to proapoptotic activity via Abeta-mediated phosphorylation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8310-9

Phosphorylation regulates tau interactions with Src homology 3 domains of phosphatidylinositol 3-kinase, phospholipase Cgamma1, Grb2, and Src family kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8310-9

Signal transduction through tyrosine-phosphorylated C-terminal fragments of amyloid precursor protein via an enhanced interaction with Shc/Grb2 adaptor proteins in reactive astrocytes of Alzheimer's disease brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8310-9

Cdk5 deregulation in the pathogenesis of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8310-9

Cleavage of p75 neurotrophin receptor by alpha-secretase and gamma-secretase requires specific receptor domains

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8310-9

Toward structural elucidation of the gamma-secretase complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8310-9

The role of the p75 neurotrophin receptor in cholinergic dysfunction in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8310-9

Beta-amyloid(1-42) induces neuronal death through the p75 neurotrophin receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8310-9

Identification of a caspase-derived N-terminal tau fragment in cellular and animal Alzheimer's disease models.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8310-9

Neurotrophin receptor-based strategies for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8310-9

APP is phosphorylated by TrkA and regulates NGF/TrkA signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8310-9

Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8310-9

Picomolar amyloid-beta positively modulates synaptic plasticity and memory in hippocampus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8310-9

Amyloid beta mediates memory formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8310-9

Amyloid beta as a regulator of lipid homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8310-9

Amyloid-beta as a positive endogenous regulator of release probability at hippocampal synapses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8310-9

Neurotrophins: mediators and modulators of pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8310-9

Intracerebroventricular infusion of nerve growth factor in three patients with Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8310-9

Nerve growth factor for the treatment of diabetic neuropathy: what went wrong, what went right, and what does the future hold?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8310-9

A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8310-9

Delivery of NGF to the brain: intranasal versus ocular administration in anti-NGF transgenic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8310-9

Development of a non invasive NGF-based therapy for Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8310-9

Mutations in the TRKA/NGF receptor gene in patients with congenital insensitivity to pain with anhidrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8310-9

Molecular basis of congenital insensitivity to pain with anhidrosis (CIPA): mutations and polymorphisms in TRKA (NTRK1) gene encoding the receptor tyrosine kinase for nerve growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8310-9

A mutation in the nerve growth factor beta gene (NGFB) causes loss of pain perception

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8310-9

In vitro receptor binding properties of a "painless" NGF mutein, linked to hereditary sensory autonomic neuropathy type V.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8310-9

Taking pain out of NGF: a "painless" NGF mutant, linked to hereditary sensory autonomic neuropathy type V, with full neurotrophic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8310-9

Bradykinin and nerve growth factor release the capsaicin receptor from PtdIns(4,5)P2-mediated inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8310-9

A modular PIP2 binding site as a determinant of capsaicin receptor sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8310-9

Intranasal "painless" human Nerve Growth Factor [corrected] slows amyloid neurodegeneration and prevents memory deficits in App X PS1 mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8310-9

The production of amyloid beta peptide is a critical requirement for the viability of central neurons.

21 January 2018

1 reference

12 December 2020

Traffic at the intersection of neurotrophic factor signaling and neurodegeneration

1 reference

12 December 2020

The effects of nerve growth factor and its antiserum on the postnatal development and survival after injury of sensory neurons in rat dorsal root ganglia

1 reference

12 December 2020

Activation of the amyloidogenic route by NGF deprivation induces apoptotic death in PC12 cells

1 reference

12 December 2020

Apoptosis in cerebellar granule cells is blocked by high KCl, forskolin, and IGF-1 through distinct mechanisms of action: the involvement of intracellular calcium and RNA synthesis

1 reference

12 December 2020

Nerve growth factor and Alzheimer's disease

1 reference

12 December 2020

Time window in cholinomimetic ability to rescue long-term potentiation in neurodegenerating anti-nerve growth factor mice

1 reference

12 December 2020

Effects of the extract of the mouse submaxillary salivary glands on the sympathetic system of mammals

1 reference

12 December 2020

Tau cleavage and dephosphorylation in cerebellar granule neurons undergoing apoptosis

1 reference

12 December 2020

Phenotypic knockout of nerve growth factor in adult transgenic mice reveals severe deficits in basal forebrain cholinergic neurons, cell death in the spleen, and skeletal muscle dystrophy.

1 reference

12 December 2020

The monomer state of beta-amyloid: where the Alzheimer's disease protein meets physiology

1 reference

12 December 2020

Environmental enrichment delays the onset of memory deficits and reduces neuropathological hallmarks in a mouse model of Alzheimer-like neurodegeneration

1 reference

12 December 2020

Possible influence of a non-synonymous polymorphism located in the NGF precursor on susceptibility to late-onset Alzheimer's disease and mild cognitive impairment.

1 reference

12 December 2020

Rapid tyrosine phosphorylation of neuronal proteins including tau and focal adhesion kinase in response to amyloid-beta peptide exposure: involvement of Src family protein kinases.

1 reference

12 December 2020

Granule neuron DNA damage following deafferentation in adult rats cerebellar cortex: a lesion model

1 reference

12 December 2020

Towards non invasive nerve growth factor therapies for Alzheimer's disease

1 reference

12 December 2020

Proteasome involvement and accumulation of ubiquitinated proteins in cerebellar granule neurons undergoing apoptosis

1 reference

12 December 2020

10.1007/S12035-012-8310-9

Identifiers

DOI

1 reference

Dimensions Publication ID

27 August 2017

1050821385

0 references

1 reference